lestaurtinib has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chisholm, C; Deng, C; Huang, R; Lahusen, TJ; Li, C; Sakamuru, S; Thomas, CJ; Vazquez-Ortiz, G; Xia, M; Xu, X | 1 |
| Afzaljavan, F; Avan, A; Ferns, GA; Hassanian, SM; Mokhtari-Zaer, A; Pasdar, A; Rezaee, M; Rivandi, M; Tajbakhsh, A | 1 |
1 review(s) available for lestaurtinib and Breast Cancer
| Article | Year |
|---|---|
Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives.
Topics: Animals; Brain-Derived Neurotrophic Factor; Breast Neoplasms; Carbazoles; Female; Furans; Humans; Membrane Glycoproteins; MicroRNAs; Neoplasm Proteins; Protein Kinase Inhibitors; Receptor, trkB; RNA Interference; RNA, Neoplasm; Wnt Signaling Pathway | 2017 |
1 other study(ies) available for lestaurtinib and Breast Cancer
| Article | Year |
|---|---|
Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azulenes; Benzodiazepines; BRCA1 Protein; Breast Neoplasms; Carbazoles; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Drug Repositioning; Drug Resistance, Neoplasm; Drug Synergism; Female; Furans; G2 Phase Cell Cycle Checkpoints; High-Throughput Screening Assays; Humans; Mice; Mice, Nude; Neoplasm Transplantation; NF-kappa B; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; RNA Interference; RNA, Small Interfering | 2014 |